| Product Code: ETC9685586 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Thailand Gastroesophageal Reflux Disease (GERD) market is witnessing steady growth driven by an increasing prevalence of GERD among the population. Factors such as changing dietary habits, rising obesity rates, and an aging population contribute to the growing number of GERD cases in Thailand. The market is characterized by a range of treatment options including medications, lifestyle modifications, and surgical interventions. Proton pump inhibitors (PPIs) are commonly prescribed for GERD management in Thailand. The market is also seeing a rise in minimally invasive surgical procedures for GERD treatment. Key players in the Thailand GERD market include pharmaceutical companies, medical device manufacturers, and healthcare providers offering specialized GERD treatments and services. Ongoing research and development activities are focused on developing innovative treatment approaches to address the growing healthcare needs associated with GERD in Thailand.
The Thailand Gastroesophageal Reflux Disease (GERD) market is experiencing a growing demand for innovative treatment options and advanced diagnostic tools. The increasing prevalence of GERD in the country, coupled with changing dietary habits and lifestyle factors, is driving the market growth. Opportunities exist for pharmaceutical companies to introduce novel medications with improved efficacy and fewer side effects. Additionally, there is a rising trend towards minimally invasive surgical procedures and endoscopic therapies for managing GERD, presenting opportunities for medical device companies. The market also shows potential for digital health solutions that enable remote patient monitoring and personalized treatment plans. Overall, the Thailand GERD market is poised for expansion, offering opportunities for companies to address unmet needs and enhance patient outcomes.
In the Thailand Gastroesophageal Reflux Disease (GERD) market, challenges include the increasing prevalence of GERD due to changing lifestyles and dietary habits, leading to a higher demand for treatment options. Additionally, there is a lack of awareness about GERD symptoms and available treatment modalities among the general population, resulting in underdiagnosis and undertreatment. The market also faces competition from various over-the-counter medications and alternative therapies, impacting the adoption of prescription drugs. Regulatory hurdles and pricing pressures further complicate market dynamics, affecting the accessibility of advanced treatment options for patients. Overall, addressing these challenges requires a comprehensive approach that involves education campaigns, improved access to healthcare services, and collaboration between healthcare providers, pharmaceutical companies, and regulatory bodies.
The Thailand Gastroesophageal Reflux Disease (GERD) market is primarily driven by a rising prevalence of GERD among the population due to lifestyle factors such as unhealthy diet, obesity, and increasing alcohol consumption. Additionally, the growing awareness about GERD symptoms and the availability of advanced diagnostic tools are fueling the demand for treatment options in the country. The increasing healthcare expenditure and improving healthcare infrastructure in Thailand are also contributing to the growth of the GERD market by facilitating better access to diagnosis and treatment services. Furthermore, the introduction of innovative pharmaceuticals and minimally invasive surgical procedures for GERD management is attracting patients seeking effective and long-term solutions, driving market expansion in Thailand.
The Thailand government has implemented various policies related to the Gastroesophageal Reflux Disease (GERD) market, aimed at improving healthcare access and quality for its citizens. These policies include the Universal Health Coverage (UHC) scheme, which provides all Thai nationals with access to essential healthcare services, including diagnosis and treatment for GERD. Additionally, the government has promoted the development of telemedicine services to enhance remote healthcare delivery, making it easier for patients with GERD to access medical consultations and monitoring. Furthermore, the Thai FDA regulates the approval and marketing of GERD medications to ensure safety and efficacy for patients. Overall, these government policies play a crucial role in shaping the landscape of the Thailand GERD market by prioritizing healthcare accessibility and quality.
The Thailand Gastroesophageal Reflux Disease (GERD) market is expected to witness steady growth in the coming years due to factors such as the rising prevalence of GERD among the population, increasing awareness about the condition, and advancements in diagnostic and treatment options. The market is likely to experience a surge in demand for medications, proton pump inhibitors, and surgical interventions for managing GERD symptoms. Additionally, the adoption of telemedicine and digital health solutions for remote monitoring and management of GERD patients is anticipated to drive market growth. However, challenges such as regulatory issues, limited access to healthcare services in rural areas, and the high cost of treatment may hinder the market expansion to some extent. Overall, the Thailand GERD market is poised for growth with opportunities for innovation and improved patient outcomes.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Gastroesophageal Reflux Disease Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Gastroesophageal Reflux Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Gastroesophageal Reflux Disease Market - Industry Life Cycle |
3.4 Thailand Gastroesophageal Reflux Disease Market - Porter's Five Forces |
3.5 Thailand Gastroesophageal Reflux Disease Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Thailand Gastroesophageal Reflux Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Gastroesophageal Reflux Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastroesophageal reflux disease (GERD) in Thailand due to changing lifestyles and dietary habits. |
4.2.2 Rising awareness about GERD among the Thai population leading to early diagnosis and treatment. |
4.2.3 Growing adoption of minimally invasive procedures for GERD management in Thailand. |
4.3 Market Restraints |
4.3.1 Limited access to advanced diagnostic tools and treatments in certain regions of Thailand. |
4.3.2 High costs associated with long-term management of GERD, including medications and procedures. |
4.3.3 Lack of skilled healthcare professionals specialized in GERD management in some healthcare facilities in Thailand. |
5 Thailand Gastroesophageal Reflux Disease Market Trends |
6 Thailand Gastroesophageal Reflux Disease Market, By Types |
6.1 Thailand Gastroesophageal Reflux Disease Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Gastroesophageal Reflux Disease Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Thailand Gastroesophageal Reflux Disease Market Revenues & Volume, By Antacids, 2021- 2031F |
6.1.4 Thailand Gastroesophageal Reflux Disease Market Revenues & Volume, By Proton Pump Inhibitors, 2021- 2031F |
6.1.5 Thailand Gastroesophageal Reflux Disease Market Revenues & Volume, By H2 Receptor Blocker, 2021- 2031F |
6.1.6 Thailand Gastroesophageal Reflux Disease Market Revenues & Volume, By Pro Kinetic Agents, 2021- 2031F |
6.1.7 Thailand Gastroesophageal Reflux Disease Market Revenues & Volume, By Dopamine Receptor Antagonist, 2021- 2031F |
6.1.8 Thailand Gastroesophageal Reflux Disease Market Revenues & Volume, By Endocinch, 2021- 2031F |
6.2 Thailand Gastroesophageal Reflux Disease Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Thailand Gastroesophageal Reflux Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.3 Thailand Gastroesophageal Reflux Disease Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.2.4 Thailand Gastroesophageal Reflux Disease Market Revenues & Volume, By General Stores, 2021- 2031F |
6.2.5 Thailand Gastroesophageal Reflux Disease Market Revenues & Volume, By Supermarkets, 2021- 2031F |
7 Thailand Gastroesophageal Reflux Disease Market Import-Export Trade Statistics |
7.1 Thailand Gastroesophageal Reflux Disease Market Export to Major Countries |
7.2 Thailand Gastroesophageal Reflux Disease Market Imports from Major Countries |
8 Thailand Gastroesophageal Reflux Disease Market Key Performance Indicators |
8.1 Average waiting time for GERD diagnosis and treatment in Thailand. |
8.2 Number of healthcare facilities offering specialized GERD management services. |
8.3 Patient satisfaction rates with GERD treatment options available in Thailand. |
9 Thailand Gastroesophageal Reflux Disease Market - Opportunity Assessment |
9.1 Thailand Gastroesophageal Reflux Disease Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Thailand Gastroesophageal Reflux Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Gastroesophageal Reflux Disease Market - Competitive Landscape |
10.1 Thailand Gastroesophageal Reflux Disease Market Revenue Share, By Companies, 2024 |
10.2 Thailand Gastroesophageal Reflux Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |